Table 5.
Tumor Stage | Gender | |||||
---|---|---|---|---|---|---|
LD-SCLC | ED-SCLC | p | Female | Male | p | |
Co-low MTV/NLR | 37 | 2 | 0.000 | 9 | 30 | 0.013 |
Low MTV/High NLR | 11 | 6 | 0 | 17 | ||
High MTV/Low NLR | 10 | 11 | 3 | 18 | ||
Co-high MTV/NLR | 14 | 28 | 2 | 40 | ||
Co-low MTV/PLR | 44 | 6 | 0.000 | 9 | 41 | 0.207 |
Low MTV/High PLR | 4 | 2 | 0 | 6 | ||
High MTV/Low PLR | 14 | 20 | 2 | 32 | ||
Co-high MTV/PLR | 10 | 19 | 3 | 26 | ||
Co-low MTV/MLR | 36 | 3 | 0.000 | 9 | 30 | 0.007 |
Low MTV/High MLR | 12 | 5 | 0 | 17 | ||
High MTV/Low MLR | 15 | 13 | 4 | 24 | ||
Co-high MTV/MLR | 9 | 26 | 1 | 34 | ||
Co-low MTV/SII | 39 | 4 | 0.000 | 9 | 34 | 0.035 |
Low MTV/High SII | 9 | 4 | 0 | 13 | ||
High MTV/Low SII | 9 | 13 | 3 | 19 | ||
Co-high MTV/SII | 15 | 26 | 2 | 39 | ||
Co-low TLG/NLR | 36 | 2 | 0.000 | 9 | 29 | 0.012 |
Low TLG/High NLR | 10 | 7 | 0 | 17 | ||
High TLG/Low NLR | 11 | 11 | 3 | 19 | ||
Co-high TLG/NLR | 15 | 27 | 2 | 40 | ||
Co-low TLG/PLR | 43 | 6 | 0.000 | 9 | 40 | 0.183 |
Low TLG/High PLR | 3 | 3 | 0 | 6 | ||
High TLG/Low PLR | 15 | 20 | 2 | 33 | ||
Co-high TLG/PLR | 11 | 18 | 3 | 26 | ||
Co-low TLG/MLR | 35 | 3 | 0.000 | 9 | 29 | 0.007 |
Low TLG/High MLR | 11 | 6 | 0 | 17 | ||
High TLG/Low MLR | 16 | 13 | 4 | 25 | ||
Co-high TLG/MLR | 10 | 25 | 1 | 34 | ||
Co-low TLG/SII | 38 | 4 | 0.000 | 9 | 33 | 0.033 |
Low TLG/High SII | 8 | 5 | 0 | 13 | ||
High TLG/Low SII | 10 | 13 | 3 | 20 | ||
Co-high TLG/SII | 16 | 25 | 2 | 39 |